Kenvue Inc.(KVUE)Company Profile & Business
NYSE

Company Profile

Business overview, scale, and footprint

Company NameKenvue Inc.
Ticker SymbolKVUE
ExchangeNYQ
SectorConsumer Defensive
IndustryHousehold & Personal Products
Employees21,780
CEOMr. Kirk L. Perry
Founded2022
HeadquartersSummit, NJ, United States
CountryUnited States
Websitekenvue.com
Next Earnings DateNov 5, 2026

Business Overview

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Insider Transactions

Open-market activity and option exercises

Insider Activity Summary

Insider trading activity for Kenvue Inc. (KVUE) between Nov 29, 2024 and Sep 25, 2026 consists of 71 total transactions. Among these, company executives and board members conducted 69 buys (totaling 7,481,111 shares) and 2 sells (totaling 42,191.296 shares). This activity resulted in a net change of 7,438,919.704 shares, reflecting net buying interest with an estimated net acquisitions value of $707.25M.

71 insider transactions found. Showing 10 of 71 transactions.

Show:entries
Insider NameRelation to CompanyShares ChangedPriceTransaction Date
STEVENS MEREDITHChief Operating Officer1,461N/ASep 25, 2026
DASGUPTA ANINDYAOfficer16,418N/AJul 31, 2026
HOWLETT HEATHERChief Financial Officer3,700$0.07Jun 10, 2026
Howlett HeatherCFO & CAO-3,700$18.11Jun 10, 2026
ORLANDO MATTHEWGeneral Counsel38,491$0.68May 8, 2026
Orlando MatthewGeneral Counsel-38,491.296$17.66May 8, 2026
CURADO GOMES DE LEMOS LEONARDOOfficer24,247N/AMay 1, 2026
STEVENS MEREDITHChief Operating Officer5,169N/AMar 10, 2026
ALVARADO LUANIChief Operating Officer4,222N/AMar 10, 2026
LAWSON CARLTONOfficer6,157N/AMar 10, 2026
Page 1 of 8 (71 total transactions)